Literature DB >> 30121936

TIMP-1 Promotes Oligodendrocyte Differentiation Through Receptor-Mediated Signaling.

Alexandra M Nicaise1, Kasey M Johnson1, Cory M Willis1, Rosa M Guzzo1, Stephen J Crocker2.   

Abstract

The extracellular protein tissue inhibitor of metalloproteinase (TIMP)-1 is both a matrix metalloproteinase (MMP) inhibitor and a trophic factor. Mice lacking TIMP-1 exhibit delayed central nervous system myelination during postnatal development and impaired remyelination following immune-mediated injury in adulthood. We have previously determined that the trophic action of TIMP-1 on oligodendrocyte progenitor cells (OPCs) to mature into oligodendrocytes is independent of its MMP inhibitory function. However, the mechanism by which TIMP-1 promotes OPC differentiation is not known. To address this gap in our understanding, herein, we report that TIMP-1 signals via a CD63/β1-integrin receptor complex to activate Akt (protein kinase B) to promote β-catenin signaling in OPCs. The regulation of β-catenin by TIMP-1 to promote OPC differentiation was counteracted, but not abrogated, by canonical signaling evoked by Wnt7a. These data provide a previously uncharacterized trophic action of TIMP-1 to regulate oligodendrocyte maturation via a CD63/β1-integrin/Akt pathway mechanism. These findings contribute to our emerging understanding on the role of TIMP-1 as a growth factor expressed to promote CNS myelination during development and induced in the adult to promote myelin repair.

Entities:  

Keywords:  Akt/PKB; Astrocyte; Metalloproteinase; Oligodendrocyte progenitor cell; Tetraspanin; Wnt7a; β-Catenin

Mesh:

Substances:

Year:  2018        PMID: 30121936      PMCID: PMC6379156          DOI: 10.1007/s12035-018-1310-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  50 in total

1.  The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2.

Authors:  Nobuo Terada; Karen Baracskay; Mike Kinter; Shona Melrose; Peter J Brophy; Claude Boucheix; Carl Bjartmar; Grahame Kidd; Bruce D Trapp
Journal:  Glia       Date:  2002-12       Impact factor: 7.452

Review 2.  The TIMPs tango with MMPs and more in the central nervous system.

Authors:  Stephen J Crocker; Axel Pagenstecher; Iain L Campbell
Journal:  J Neurosci Res       Date:  2004-01-01       Impact factor: 4.164

3.  Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes.

Authors:  Carlo Avolio; Maddalena Ruggieri; Fabrizio Giuliani; Grazia Maria Liuzzi; Rosaria Leante; Paolo Riccio; Paolo Livrea; Maria Trojano
Journal:  J Neuroimmunol       Date:  2003-03       Impact factor: 3.478

4.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.

Authors:  Christopher Lock; Guy Hermans; Rosetta Pedotti; Andrea Brendolan; Eric Schadt; Hideki Garren; Annette Langer-Gould; Samuel Strober; Barbara Cannella; John Allard; Paul Klonowski; Angela Austin; Nagin Lad; Naftali Kaminski; Stephen J Galli; Jorge R Oksenberg; Cedric S Raine; Renu Heller; Lawrence Steinman
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

5.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

Authors:  Ansi Chang; Wallace W Tourtellotte; Richard Rudick; Bruce D Trapp
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

6.  Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; B Volk; I L Campbell
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.

Authors:  A Chang; A Nishiyama; J Peterson; J Prineas; B D Trapp
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

Review 8.  Why does remyelination fail in multiple sclerosis?

Authors:  Robin J M Franklin
Journal:  Nat Rev Neurosci       Date:  2002-09       Impact factor: 34.870

9.  The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation.

Authors:  Peter H Larsen; V Wee Yong
Journal:  J Neurosci       Date:  2004-09-01       Impact factor: 6.167

Review 10.  Complexes of tetraspanins with integrins: more than meets the eye.

Authors:  F Berditchevski
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

View more
  11 in total

1.  Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination.

Authors:  Evelien Houben; Kris Janssens; Doryssa Hermans; Jennifer Vandooren; Chris Van den Haute; Melissa Schepers; Tim Vanmierlo; Ivo Lambrichts; Jack van Horssen; Veerle Baekelandt; Ghislain Opdenakker; Wia Baron; Bieke Broux; Helena Slaets; Niels Hellings
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

2.  Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes.

Authors:  Valéria de Almeida; Gabriela Seabra; Guilherme Reis-de-Oliveira; Giuliana S Zuccoli; Priscila Rumin; Mariana Fioramonte; Bradley J Smith; Antonio W Zuardi; Jaime E C Hallak; Alline C Campos; José A Crippa; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-05-27       Impact factor: 5.760

3.  Tissue Inhibitor of Metalloprotease-1 (TIMP-1) Regulates Adipogenesis of Adipose-derived Stem Cells (ASCs) via the Wnt Signaling Pathway in an MMP-independent Manner.

Authors:  Lu Wang; Chen-Guang Zhang; Yu-Lin Jia; Li Hu
Journal:  Curr Med Sci       Date:  2020-10-29

4.  Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke.

Authors:  Ligen Shi; Zeyu Sun; Wei Su; Fei Xu; Di Xie; Qingxiu Zhang; Xuejiao Dai; Kartik Iyer; T Kevin Hitchens; Lesley M Foley; Sicheng Li; Donna B Stolz; Kong Chen; Ying Ding; Angus W Thomson; Rehana K Leak; Jun Chen; Xiaoming Hu
Journal:  Immunity       Date:  2021-05-19       Impact factor: 43.474

5.  Functional in vivo assessment of stem cell-secreted pro-oligodendroglial factors.

Authors:  Jessica Schira-Heinen; Iria Samper Agrelo; Veronica Estrada; Patrick Küry
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

6.  Secretome Analysis of Mesenchymal Stem Cell Factors Fostering Oligodendroglial Differentiation of Neural Stem Cells In Vivo.

Authors:  Iria Samper Agrelo; Jessica Schira-Heinen; Felix Beyer; Janos Groh; Christine Bütermann; Veronica Estrada; Gereon Poschmann; Ana Bribian; Janusz J Jadasz; Laura Lopez-Mascaraque; David Kremer; Rudolf Martini; Hans Werner Müller; Hans Peter Hartung; James Adjaye; Kai Stühler; Patrick Küry
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

Review 7.  Glia and Neural Stem and Progenitor Cells of the Healthy and Ischemic Brain: The Workplace for the Wnt Signaling Pathway.

Authors:  Tomas Knotek; Lucie Janeckova; Jan Kriska; Vladimir Korinek; Miroslava Anderova
Journal:  Genes (Basel)       Date:  2020-07-16       Impact factor: 4.096

8.  TIMP-1 Attenuates the Development of Inflammatory Pain Through MMP-Dependent and Receptor-Mediated Cell Signaling Mechanisms.

Authors:  Brittany E Knight; Nathan Kozlowski; Joshua Havelin; Tamara King; Stephen J Crocker; Erin E Young; Kyle M Baumbauer
Journal:  Front Mol Neurosci       Date:  2019-09-20       Impact factor: 5.639

9.  Time-Course Changes of Extracellular Matrix Encoding Genes Expression Level in the Spinal Cord Following Contusion Injury-A Data-Driven Approach.

Authors:  Andrea Bighinati; Zahra Khalajzeyqami; Vito Antonio Baldassarro; Luca Lorenzini; Maura Cescatti; Marzia Moretti; Luciana Giardino; Laura Calzà
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

10.  Ethyl Pyruvate-Derived Transdifferentiation of Astrocytes to Oligodendrogenesis in Cuprizone-Induced Demyelinating Model.

Authors:  Yan He; Jun An; Jun-Jun Yin; Qiang Miao; Ruo-Xuan Sui; Qing-Xian Han; Zhi-Bin Ding; Jian-Jun Huang; Cun-Gen Ma; Bao-Guo Xiao
Journal:  Neurotherapeutics       Date:  2020-11-02       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.